Skip to main content
. 2020 Jan 3;21(3):1251–1257. doi: 10.3892/mmr.2020.10908

Figure 4.

Figure 4.

Role and molecular mechanism of birinapant in hepatocellular carcinoma cell proliferation. (A) Subcutaneous tumors in each experimental group. (B) Immunohistochemistry was used to assess the protein expression levels of PCNA and caspase-3 in subcutaneous tumors; magnification, ×400. *P<0.05, **P<0.01. cIAP1, cellular inhibitor of apoptosis 1; Con, control; shRNA, short hairpin RNA; Nega, negative control; PCNA, proliferating cell nuclear antigen; TRAF3, tumor necrosis factor receptor-associated factor 3.